Member Info for roses

Just done a dummy quote

21.39 to buy 10k
21.50 to sell 10k

Market makers desperate for shares !!!!

Half year report and possible covid trial update is due in exactly 2 weeks from today, I would expect a steady increase in the share price as we approach it.

Interesting, maximum you can buy is 75k

Morning c7 , You would think increasing interest in the share and increased liquidity.

Sclp has a new market maker today, Marex (MREX) up to 9 now from 8

With the EMA now saying that regular booster shots won’t work, scancells interim covid results due out shortly in which they state should last for ‘SEVERAL YEARS’ couldn’t come at a better time.

https://www.bloombergquint.com/onweb/repeat-booster-shots-risk-overloading-immune-system-ema-says

https://www.ft.com/content/49641651-e10a-45f6-a7cc-8b8c7b7a9710

Either way, we all know omicron is definitely not going to be the last variant.
Unfortunately there will be plenty more to rear their heads in the near future.

https://www.bloomberg.com/news/articles/2022-01-08/cyprus-finds-covid-19-infections-that-combine-delta-and-omicron

The company said the interim results from the covid trial will be released from late January , so not long to wait .

If the results come even close to what scancell say it can do then the share price will absolutely explode and would expect immunobody platform to be bought out by a major pharmaceutical company within months if not weeks after the results and wouldn’t be surprised to see a bidding war on it !

Excellent post and I don’t remember seeing this bit before

“A vaccine encoding both nucleocapsid protein linked to a modified Fc and receptor-binding domain should stimulate long-term memory B and T cells, and should give sustained protection over several years. This will give less opportunities for variants to arise and prevent people from having to be vaccinated every six months.”

Apologies johnny, I didn’t read your post properly

The second dose is on day 29 which has already passed for some patients and the third dose will be given on day 113 (jan 26)

“COVIDITY consists of two doses of the plasmid DNA vaccine SCOV1 (administered on Day 1 and Day 29), followed by two doses of the plasmid DNA vaccine SCOV2 (not before Days 113 and 141 [doses 4 weeks apart])”

I wouldn’t discount anything yet. Nothing goes up in a straight line.

Live on Bloomberg prof. Rohn from UCL saying we need new vaccines.

Morning C7, no surprise at all that the sp is rising. We are due the interim results from the covid trial in the next few weeks that in itself should propel the sp higher from here.
Not to mention that the modi1 trial is about to start and we could get a deal any time now for the mabs.

A very exciting time to be a SCLP holder.

https://www.express.co.uk/news/science/1544585/covid-news-uk-monitoring-new-variant-detected-in-france-ihu-coronavirus-cameroon

Latest ut trade at 22p